Soleno Therapeutics to present new long-term DCCR fata at largest-ever Prader-Willi Syndrome Conference
Soleno Therapeutics, Inc, a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced one oral and six poster presentations at the 2025 United In… read more.
